Literature DB >> 6541758

Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.

L M Attila, L Ahtee.   

Abstract

To clarify the effects of withdrawal from chronic morphine treatment on cerebral noradrenaline (NA) turnover, we have measured the alpha-methyl-p-tyrosine (alpha MT)-induced depletion of NA in five brain areas of male Wistar rats given morphine twice daily for 40 or 60 days. After the last morphine dose (50 or 70 mg/kg) the rats were withdrawn for 1, 2 or 4 days. In order to study the development of tolerance a challenge dose of 10 mg/kg of morphine was given to some of the rats. Withdrawal of morphine accelerated the alpha MT-induced NA depletion clearly in the hemispheres and the lower brain stem and slightly in the diencephalon. The acceleration was more pronounced in the brains of rats treated for 60 days than of those treated for 40 days. In the hemispheres the acceleration of NA depletion occurred at 1 and 2 days, in the diencephalon at 2 days, and in the lower brain stem at 2 and 4 days after morphine withdrawal. The most pronounced acceleration of NA depletion coincided with the maximum withdrawal-induced weight loss. The challenge dose of morphine clearly retarded the alpha MT-induced NA depletion in the hemispheres of control rats treated chronically with saline. This retardation was even more pronounced in rats withdrawn from chronic morphine treatment for 1 or 2 days. The challenge dose slightly accelerated the alpha MT-induced NA depletion in the lower brain stem of control rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6541758     DOI: 10.1007/bf00502449

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal.

Authors:  L M GUNNE
Journal:  Acta Physiol Scand Suppl       Date:  1963

2.  The addiction cycle to narcotics in the rat and its relation to catecholamines.

Authors:  T Akera; T M Brody
Journal:  Biochem Pharmacol       Date:  1968-05       Impact factor: 5.858

3.  Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

4.  Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo.

Authors:  A Carlsson; M Lindqvist
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

5.  Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices.

Authors:  H Montel; K Starke; F Weber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats.

Authors:  R Laverty; R H Roth
Journal:  Brain Res       Date:  1980-01-27       Impact factor: 3.252

7.  Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.

Authors:  B B Brodie; E Costa; A Dlabac; N H Neff; H H Smookler
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

8.  Enkephalin: a potential modulator of noradrenaline release in rat brain.

Authors:  H D Taube; E Borowski; T Endo; K Starke
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

9.  The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain.

Authors:  M F Sugrue
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

10.  Morphine tolerance and dependence in the locus coeruleus: single cell studies in brain slices.

Authors:  R Andrade; C P Vandermaelen; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1983-07-22       Impact factor: 4.432

View more
  6 in total

1.  Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats.

Authors:  A Zharkovsky; A M Tötterman; J Moisio; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

2.  Effect of alpha 2-adrenoceptor agonists on the expression of morphine-withdrawal in rats.

Authors:  I M Coupar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

3.  Effects of naloxone-precipitated withdrawal after a single dose of morphine on catecholamine concentrations in guinea-pig brain.

Authors:  P J Brent; L A Chahl
Journal:  Neurochem Res       Date:  1991-05       Impact factor: 3.996

4.  Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.

Authors:  L M Attila; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

5.  Changes induced by sodium cromoglycate in brain catecholamine turnover in morphine dependent and abstinent mice.

Authors:  O San-Martín-Clark; B Cuéllar; J De Alba; J C Leza; P Lorenzo
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

6.  Effect of morphine and abstinence syndrome on [3H]bromoxidine binding to alpha 2-adrenoceptors in rat brain.

Authors:  A Fernández-López; C Soria; V Revilla; T Gómez; P Calvo
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.